Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company ...
A research team led by The Hong Kong University of Science and Technology (HKUST) has developed a pioneering artificial ...
Oregon Health & Science University researchers have developed a first-of-its-kind method to predict cancer patient survival ...
An AI model applied to pathology slides accurately predicts immunotherapy response in patients with metastatic non-small cell ...
Nearly half of people diagnosed with advanced cancer over a recent 5-year period did not undergo next-generation sequencing, according to results of a retrospective cohort study.Rates improved over ...
Cancer clues in pleural effusions are often rare, fragile, and easy to miss. Single malignant tumor cells (MTCs) can help ...
In a National Institutes of Health (NIH)-funded study, researchers developed a cancer assessment tool that can identify high-risk patients and the tumor cells linked to that risk.
The field of lung cancer research has increasingly turned its attention to the tumor immune microenvironment (TIME) in non-small cell lung cancer (NSCLC), ...
Cancer immunology is advancing rapidly as researchers seek to unravel the complex, dynamic relationships between tumor cells, immune populations, and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results